Business Today: Latest Business News, India economy News, Stock Markets, Sensex, Mutual Funds and Indian Tax
Loading...
Search

Total 10000 results found. Search for [ P ]

Results 80 to 100 of 10000
Associated Press
April 21, 2021
The restrictions come in addition to those previously announced regarding four other countries -- Brazil, Argentina, Chile and Brazil -- that will be implemented starting from Saturday


BusinessToday.In
April 21, 2021
During the first COVID-19 wave, the demand for liquid medical oxygen went up from 700 metric tonnes per day (MTPD) to 2,800 MTPD. But during the second wave, it has further skyrocketed to 5,000 MTPD


BusinessToday.In
April 21, 2021
Modi, in his address to the nation on Tuesday night, said that the government would ensure the supply of medical oxygen across India, with the help of both public and private entities


BusinessToday.In
April 21, 2021
While the Grofers CEO Albinder Dhindsa didn't reveal how many orders were finally placed, the spike in carts is a good enough example of how people feared another nationwide lockdown


Sumant Banerji
April 21, 2021
This is the first direct foray of Hero MotoCorp in the nascent but fast moving two-wheeler EV space. It has also invested in EV start-up Ather where it is the largest shareholder with a 35 per cent stake


BusinessToday.In
New Delhi, April 21, 2021
India's indigenous COVID-19 vaccine Covaxin is effective against multiple variants, including the double mutant variant of SARS-CoV-2, the Indian Council of Medical Research (ICMR) said on Wednesday. The ICMR said the studies showed that Covaxin also neutralised the UK and Brazil variants of SARS-CoV-2, the coronavirus that causes COVID-19. The double mutant variant is expected to have fuelled the second wave of COVID-19 pandemic in India. Covaxin was developed in collaboration with the ICMR, the National Institute of Virology (NIV) and vaccine manufacturer Bharat Biotech. It was developed using a sample of coronavirus isolated by the NIV. Watch the video for more.Also Read: COVID-19 vaccination: India needs 8 yrs 9 months to achieve herd immunity


BusinessToday.In
April 21, 2021
Over the past 50 days, 9.78 crore Indians got the first shot of the vaccine, whereas the second dose was administered to a little over 1.5 crore Indians


Sarthak Dogra
Noida, April 21, 2021
Apple has released the guidelines for app developers to follow for its upcoming version of the iOS. The guidelines will be put to effect starting April 26.


BusinessToday.In
New Delhi, April 21, 2021
Prime Minister Narendra Modi addressed the nation on Tuesday and spoke about the prevailing COVID-19 situation in the country. He said the situation in India was under control until some weeks ago, but the second wave of COVID has come like a storm. The Prime Minister said India is currently fighting a very tough battle against COVID-19 and urged people to follow COVID-appropriate behaviour. In his address to the nation, PM Modi thanked doctors, medical staff, paramedical staff, ambulance drivers, security forces and police for their services during the pandemic. He also added that India is fortunate to have a strong pharma sector that makes quality medicines speedily. Watch the video for more.Also Read: Bharat Biotech's Covaxin 78% effective; works against most COVID-19 variants


Sarthak Dogra
Noida, April 21, 2021
In a recent response to a Twitter user, Elon Musk clarified the facts on how he opted to start up his own venture instead of getting a job in 1995.


BusinessToday.In
April 21, 2021
Union Home Minister Amit Shah also condoled the loss of life in the incident


BusinessToday.In
April 21, 2021
Congress leader Priyanka Gandhi Vadra said that foreign agencies purchased COVID vaccines from Indian manufacturers much before the Modi government. India placed its first order in January 2021, she added


BusinessToday.In
April 21, 2021
The new variant, B.1.618 is also called a major immune escape variant, as it can escape immunity even if a person has contracted the virus before and can produce antibodies against it


PTI
April 21, 2021
Of this, 15 states and union territories have only given Covishield, being manufactured by the Pune-based Serum Instiute of India


Joe C Mathew
April 21, 2021
\"Efficacy against SARS-Cov-2 has been established. COVAXIN has demonstrated an excellent safety record in human clinical trials and in usage under emergency use,\" said Dr Krishna Ella, MD & Chairman, Bharat Biotech


BusinessToday.In
April 21, 2021
The ICMR has said that the vaccine developed by Bharat Biotech is effective against the UK and Brazil variants of SARS-CoV-2 and the double mutant strain of the virus


BusinessToday.In
New Delhi, April 21, 2021
Congress leader P Chidambaram on Tuesday slammed the government over its revised vaccine policy.  Chidambaram stated that the new vaccine policy is 'heartless' and 'lacks vision'; To support vaccination campaigns in India and across the globe, Bharat Biotech has ramped up the manufacturing capacity of its COVID-19 vaccine, Covaxin, to 700 million doses per annum, the vaccine maker said on Tuesday; Finance Minister Nirmala Sitharaman on Tuesday, April 20, said that there should be absolute trust between the industry and the government to support growth in the wake of the COVID-19 situation in the country. Watch this and more on News Blast.Also Read: 22 patients die in Nashik hospital after oxygen leak from tanker


BusinessToday.In
New Delhi, April 21, 2021
In a tragic incident today, 22 people died after an oxygen tanker leaked outside a hospital in Maharashtra's Nashik causing oxygen supply to be halted for around 30 minutes.  The incident took place at the city's Zakir Hussain Hospital. Watch the video for more details.


BusinessToday.In
April 21, 2021
\"People died because the pressure reduced due to the leak in the oxygen tank which is provided by a private company,\" said Nashik Collector Suraj Mandhare


PTI
April 21, 2021
While reserving its decision, the court had observed that the order of the Competition Commission of India (CCI) does not reflect an investigation into abuse of dominant position and rather appears to be concerned with privacy issues of consumers


PAGES 5 OF 500  12345